Literature DB >> 6117565

Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.

C Fischer, K Maier, U Klotz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6117565     DOI： 10.1016/s0378-4347(00)80303-5

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  11 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Specific measurement of 5-aminosalicylic acid and its acetylated metabolite in human bile.

Authors:  C Fischer; K Maier; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

3.  Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

Authors:  W Kruis; S Schreiber; D Theuer; J W Brandes; E Schütz; S Howaldt; B Krakamp; J Hämling; H Mönnikes; I Koop; M Stolte; D Pallant; U Ewald
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

4.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

5.  Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.

Authors:  C Fischer; K Maier; E Stumpf; U von Gaisberg; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man.

Authors:  U Diener; H V Tuczek; C Fischer; K Maier; U Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

7.  Is N-acetylation of 5-aminosalicylic acid reversible in man?

Authors:  C O Meese; C Fischer; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

8.  Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution.

Authors:  R K Palsmeier; D M Radzik; C E Lunte
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

9.  Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.

Authors:  Tessa E H Römkens; Rene Te Morsche; Wilbert Peters; David M Burger; Frank Hoentjen; Joost P H Drenth
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

10.  [Significance of galenic preparations for luminal release of 5-aminosalicylic acid in human small intestinal lumen].

Authors:  J Keller; H Goebell; U Klotz; P Layer
Journal:  Med Klin (Munich)       Date:  1998-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.